Increased risk of chronic kidney disease in people with ‘healthy’ obesity
People with ‘healthy’ obesity have a 66% increased risk of chronic kidney disease compared to metabolically healthy individuals with normal weight, finds a new study led by the University of Birmingh…
Young patients with cancer to benefit from £1million investment in genomic testing
Children and young people living with cancer from across the West Midlands, Oxfordshire and parts of Southern England will now benefit from improved genetic testing, thanks to a seven-figure donation…
Better treatment for miscarriage patients is also more cost effective
A new drug combination that is better at treating miscarriage is also more cost effective than current standard NHS treatment, finds a new study led by BHP founder-member the University of Birmingham…
Revolutionising diagnosis and treatment of life-threatening post-partum haemorrhage
Post-partum haemorrhage (PPH) accounts for 27% of all maternal deaths worldwide, according to the World Health Organization (WHO). The burden of PPH disproportionately affects mothers from low- and m…
Bayer to invest in childhood cancer trial at the University of Birmingham
Significant funding from Bayer, a global enterprise with core competencies in the life science fields of healthcare and nutrition, is enabling the University of Birmingham’s Cancer Research UK Clinic…
University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb
BHP founder-member the University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects by fast-tracking research from lab to patient.
Birmingham is…